Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Future of Chemistry R&D Will Depend on Deep Learning

Posted on June 7th, 2018 by in Pharma R&D

A recent survey of chemists, carried out by Elsevier’s Reaxys team, showed that only 13% identified a familiarity with machine learning (or similar technologies) as being important for future chemists. (more…)

Big Talks on Big Data are Coming to Bio IT World

Posted on May 9th, 2018 by in Pharma R&D

At next week’s Bio IT World conference and expo (Boston, May 15-17), Elsevier will be giving four talks on the implications of AI and machine learning on life science research, a statistical analysis of concordance between animal toxicities and human adverse events, strategies for increasing data sharing and the latest technologies being used to integrate multiple data sources. (more…)

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. (more…)

Managing Data and the Digital Revolution with Emerging Technologies

Posted on November 13th, 2017 by in Pharma R&D

The scholarly publishing industry has experienced major shifts in the last few decades. Research journals have long captured the insights of scientific research, further fueling the work of other scientists. (more…)

  1. 1
  2. …
  3. 3
  4. 4
  5. 5
  6. 6